Self-monitoring and self-management of oral anticoagulant therapy
HAYES, Inc.
Record ID 32006001584
English
Authors' objectives:
Patients receiving long-term oral anticoagulation therapy (OAT) can monitor their own coagulation control with portable devices that measure capillary whole-blood prothrombin time (PT). The anticoagulant activity of warfarin is monitored by the prothrombin time (PT) using the International Normalized Ratio (INR). After testing, patients either notify their physicians of the results or use an individualized algorithm to adjust their warfarin dosage to maintain PT within a target zone. The goal of self-monitoring and self-management of PT is to improve anticoagulation control and reduce the frequency of adverse events.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2327
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Anticoagulants
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.